International Journal of Cancer

Papers
(The H4-Index of International Journal of Cancer is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Issue Information285
Issue Information198
Issue Information182
157
116
Physical activity and mortality in melanoma patients within the Norwegian Women and Cancer study (NOWAC)110
Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer101
Issue Information100
Latent class analysis‐derived classification improves the cancer‐specific death stratification of lymphomas: A large retrospective cohort study97
Cervical cancer screening: Sharing best practices and addressing common challenges in cervical cancer screening programs86
Erratum83
Issue Information77
Identification of pre‐diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis: A nested case‐control study within the ATBC cohort76
Mediation effect of intestinal microbiota on the relationship between fiber intake and colorectal cancer68
DCLK1 in gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target67
Dipeptidyl peptidase‐4 in the tumor microenvironment of the digestive system: Molecular mechanisms and therapeutic targets64
Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population63
New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities61
Celecoxib promotes the efficacy of STING‐targeted therapy by increasing antitumor CD8+ T‐cell functions via modulating glucose metabolism of CD11b+57
Changes in cancer incidence rates by stage during the COVID‐19 pandemic in the US57
tRNA‐derived fragments: Unveiling new roles and molecular mechanisms in cancer progression57
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials56
Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study56
Pan‐cancer analysis reveals molecular signatures for predicting matrix stiffness in solid tumors55
Mammographic breast density, body mass index and risk of breast cancer in Korean women aged 75 years and older55
Body mass index and body shape before treatment and nasopharyngeal carcinoma prognosis: A population‐based patient cohort study in southern China55
Association of aflatoxin with gallbladder cancer in a case‐control study nested within a Chinese cohort55
The landscape of genetic aberrations in myxofibrosarcoma54
Polymorphisms within autophagy‐related genes as susceptibility biomarkers for pancreatic cancer: A meta‐analysis of three large European cohorts and functional characterization53
Issue Information53
52
Comments on “Methylation scores for smoking, alcohol consumption and body mass index and risk of seven types of cancer”51
Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration d51
Ovarian cancer survival in sub‐Saharan Africa by human development index and histological subtypes: A population‐based registry study50
Improving colon cancer screening in Poland. In search of the Holy Grail49
Socioeconomic position and risk of cervical cancer in the Nordic countries: Results from the Nordic Occupational Cancer Study49
Pre‐diagnostic circulating resistin concentrations and mortality among individuals with colorectal cancer: Results from the European Prospective Investigation into Cancer and Nutrition study48
Immune‐related conditions and cancer‐specific mortality among older adults with cancer in the United States48
Timing of surgery and 1‐year postoperative outcomes in patients with breast cancer and preoperative COVID‐19 history: A matched, longitudinal, ambidirectional cohort study48
The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center47
Differences in survival and recurrence of colorectal cancer by stage across population‐based European registries47
Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population‐based cohort study47
Antiviral prophylaxis for hepatitis B virus reactivation in T‐cell lymphoma patients with resolved hepatitis B virus infection47
Trends in cancer incidence by socioeconomic deprivation in Germany in 2007 to 2018: An ecological registry‐based study46
Longitudinal associations of plasma metabolites with persistent fatigue among colorectal cancer survivors up to 2 years after treatment44
Household air pollution and risk of incident lung cancer in urban China: A prospective cohort study44
0.063074111938477